Open Demat Account
Become a
New
Partner
Products &
Services
Financial
Planning
Analyse
Portfolio
Investment
Platforms
Login
Flip
FundsGenie
Smartfolios
TraderX
MyGeojit
Open Demat Account
Support
Equity
Mutual Funds
Portfolio Management
Currency Futures
IPO
Smartfolios
NEW
Sovereign Gold Bond
Commodity
Insurance
Depository Services
Global Investments
NEW
Margin Trading Funding
Private Wealth
NRI Services
FundsGenie for Mutual Funds
Mutual Funds Sahi Hai!
Login to FundsGenie
Or Download the Mobile App
Equity
Margin Trading Funding
Smartfolios
NEW
Currency Futures
Depository Services
Commodity
IPO
Sovereign Gold Bond
To avail the service, you will be redirected to loans.geojitcredits.com
Continue
Close
Search
ALL
Company
News
NAV
Site Search
Please wait ...
Home
Equity
Index Details -Pharmaceuticals - Indian - Formulations
Share
Bafna Pharmaceuticals Ltd Share Price
Pharmaceuticals - Indian - Formulations
Buy
Ask Expert
Background
Balance sheet
Profit & Loss
Quarterly Results
Share Prices
Bonus History
Capital History
Key Financial Ratios
Director's Report
Score Board
Peer Comparison
Deliverable Volumes
NSE
BSE
172.80
171.65
Date :
Sep 29,2025 EOD
-3.53
(-2.00)
-2.00
(-3.50)
1D
1W
1M
3M
1Y
Stock Price Details
Open Price
(₹)
172.80
Buy (size)
0.00(x0)
Sell (size)
0.00(×0)
Buy Qty
0
Sell Qty
0
Today's High
(₹)
172.80
Today's Low
(₹)
172.80
52 Week High
(₹)
176.33
52 Week Low
(₹)
69.00
Market Statistics
Div Yield (%)
0
EPS
4.25
Book Value
35.85
Market Cap
406.06
Face Value
10
Market Lot
1
AGM Date
Sep
Closure Date
ISIN No
INE878I01022
Share Holding Pattern
Total Foreign (Promoter & Group)
0
Indian (Promoter & Group)
17742251
Total of Promoter
17742251
Non Promoter (Institution)
2209803
Non Promoter (Non-Institution)
3704281
Total Non Promoter
5914084
Total Promoter & Non Promoter
23656335
Custodians(Against Depository Receipts)
0
Grand Total
23656335
News
Bafna Pharmaceuticals Ltd
Bafna Pharmaceuticals Ltd - Bafna Pharmaceuti..
26-Sep-2025
Read More
Bafna Pharmaceuticals Ltd
Bafna Pharmaceuticals Ltd - Bafna Pharmaceuticals Limited - Trading Window
Bafna Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Bafna Pharmaceuticals Ltd
Bafna Pharmaceuticals Ltd - Bafna Pharmaceuti..
26-Sep-2025
Read More
Bafna Pharmaceuticals Ltd
Bafna Pharmaceuticals Ltd - Bafna Pharmaceuticals Limited - Trading Window
Bafna Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Bafna Pharmaceuticals Ltd
Bafna Pharmaceuticals Ltd - Shareholder Meeti..
19-Sep-2025
Read More
Bafna Pharmaceuticals Ltd
Bafna Pharmaceuticals Ltd - Shareholder Meeting / Postal Ballot-Outcome of AGM
We herewith enclose the Outcome / Proceedings of the 30th Annual General Meeting of the Company held on September 19 2025.
Bafna Pharmaceuticals Ltd
Bafna Pharmaceuticals Ltd - Bafna Pharmaceuti..
28-Aug-2025
Read More
Bafna Pharmaceuticals Ltd
Bafna Pharmaceuticals Ltd - Bafna Pharmaceuticals Limited - Copy of Newspaper Publication
Bafna Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication in connection with the 30th Annual General Meeting of the Company
Bafna Pharmaceuticals Ltd
Bafna Pharmaceuticals Ltd - Reg. 34 (1) Annua..
26-Aug-2025
Read More
Bafna Pharmaceuticals Ltd
Bafna Pharmaceuticals Ltd - Reg. 34 (1) Annual Report.
We herewith enclose the Annual Report of the Company for the F.Y 2024-2025.
Bafna Pharmaceuticals Ltd
Bafna Pharmaceuticals Ltd - Bafna Pharmaceuti..
21-Aug-2025
Read More
Bafna Pharmaceuticals Ltd
Bafna Pharmaceuticals Ltd - Bafna Pharmaceuticals Limited - Shareholders meeting
Bafna Pharmaceuticals Limited has informed the Exchange regarding Intimation of 30th Annual General Meeting to be held on September 19, 2025
Bafna Pharmaceuticals Ltd
Bafna Pharmaceuticals AGM scheduled
20-Aug-2025
Read More
Bafna Pharmaceuticals Ltd
Bafna Pharmaceuticals AGM scheduled
Bafna Pharmaceuticals announced that the 30th Annual General Meeting(AGM) of the company will be held on 19 September 2025.
Bafna Pharmaceuticals Ltd
Bafna Pharmaceuticals Ltd - Bafna Pharmaceuti..
14-Aug-2025
Read More
Bafna Pharmaceuticals Ltd
Bafna Pharmaceuticals Ltd - Bafna Pharmaceuticals Limited - Copy of Newspaper Publication
Bafna Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication of the Extract of the Unaudited Financial Results of the Company for the Quarter ended June 30, 2025 in 'Business Standard' and 'Makkal Kural' on August 14, 2025.
Bafna Pharmaceuticals Ltd
Bafna Pharmaceuticals reports standalone net ..
12-Aug-2025
Read More
Bafna Pharmaceuticals Ltd
Bafna Pharmaceuticals reports standalone net profit of Rs 3.39 crore in the June 2025 quarter
Net profit of Bafna Pharmaceuticals reported to Rs 3.39 crore in the quarter ended June 2025 as against net loss of Rs 0.72 crore during the previous quarter ended June 2024. Sales rose 4.00% to Rs 34.62 crore in the quarter ended June 2025 as against Rs 33.29 crore during the previous quarter ended June 2024.
Particulars
Quarter Ended
Jun. 2025
Jun. 2024
% Var.
Sales
34.62
33.29
4
OPM %
14.64
3.63
-
PBDT
4.76
1.07
345
PBT
3.39
-0.37
LP
NP
3.39
-0.72
LP
Bafna Pharmaceuticals Ltd
Bafna Pharmaceuticals Ltd - Bafna Pharmaceuti..
12-Aug-2025
Read More
Bafna Pharmaceuticals Ltd
Bafna Pharmaceuticals Ltd - Bafna Pharmaceuticals Limited - Outcome of Board Meeting
Bafna Pharmaceuticals Limited has informed the Exchange regarding the outcome Board meeting held on August 12, 2025
Corporate Details
Board of Directors
Incorporation Year
1995
Chairman
Auditor
Brahmayya & Co
Face Value
10
Market Lot
1
Listing
BSE,MSEI,NSE,
Registered Office
NA     
Contact
Telephone: 91-44-25267517/25270992/4267755
Fax: 91-44-25231264/42677599
Whole Time Director
Shanmugam Hemalatha
Non-Executive & Non-Independent Director
Akilapriya Chandrashekar Raju
Non Executive & Independent Director
Ravichandran Chitra
Non Executive Director
Upendar Mekala Reddy
Whole-time Director
Vinayak Dinesh Dendukuri
Company Sec. & Compli. Officer
A Mohanachandran
Additional Director
Navin Kumar
Non Executive Director
Palamadai Krishnan Sundaresan
Mutual Fund Holdings
1-0
of 0
Scheme Name
Amount Invested (Cr )
% Net Assets
Total Nav (Cr)
FAQ
What is the share price of Bafna Pharmaceuticals Ltd today on NSE and BSE?
The Bafna Pharmaceuticals Ltd Share price on NSE is Rs.172.80 and BSE Rs.171.65 as on today
How to buy Bafna Pharmaceuticals Ltd shares Online?
You can easily open a Demat account online with Geojit and buy Bafna Pharmaceuticals Ltd shares through Flip/Selfie – Geojit’s advanced trading platform.
What is the Market Capitalization of Bafna Pharmaceuticals Ltd?
Market capitalization is a way of evaluating the value of a company. It refers to the total value of all a company's shares of stock. The market capitalization of Bafna Pharmaceuticals Ltd is 406.06
What are the key financial ratios to analyse Bafna Pharmaceuticals Ltd Share Price?
Bafna Pharmaceuticals Ltd share can be evaluated based on following ratios as on March 2023
Shares P/E ratio: 40.39
ROE ratio: 4.98
Debt to Equity ratio: 0.32
EPS: 4.25
When did Bafna Pharmaceuticals Ltd gave bonus shares last?
The issue of bonus shares enhances the company's value and improve positions in the market by gaining the trust of existing shareholders. The Bafna Pharmaceuticals Ltd issued bonus shares last in NA
What is the 52 week highest and lowest share price value of Bafna Pharmaceuticals Ltd?
The highest share price value is Rs. 176.33 and Lowest share price value is Rs. 69.00 for 52 week period for Bafna Pharmaceuticals Ltd.
Which ETF or Mutual Fund Holding has the highest amount invested with Bafna Pharmaceuticals Ltd?
NA has the highest amount invested with Bafna Pharmaceuticals Ltd.
Which year Bafna Pharmaceuticals Ltd was incorporated?
Bafna Pharmaceuticals Ltd was incorporated in 1995
What is the stock symbol of Bafna Pharmaceuticals Ltd?
The stock symbol for Bafna Pharmaceuticals Ltd shares is BAFNAPHARMACEUTICALSLTD.
Peer Comparison
Option Type
Balance Sheet
Financial Ratios
Profit & Loss
Select
Company Name
BSE Code
NSE Symbol
ABL Bio-Technologies Ltd
526955
Not Listed
ACE Laboratories Ltd
526077
ACELAB
Adline Chem Lab Ltd
524604
Not Listed
Aesculapius Remedies Ltd (Wound-up)
531786
Not Listed
Ahlcon Parenterals (India) Ltd
524448
Not Listed
Ajanta Pharma Ltd
532331
AJANTPHARM
Alps Laboratories Ltd
526003
Not Listed
American Remedies Ltd (Merged)
531534
Not Listed
Amrutanjan Health Care Ltd
590006
AMRUTANJAN
Ankur Drugs & Pharma Ltd
531683
ANKURDRUGS
Please wait ...
Deliverable Volumes
Exchange
BSE
NSE
From Date
To Date
Date
Quantity Traded
Quantity Delivered
Change %
16 Sep 2025
73,084.00
39,148.00
53.57
15 Sep 2025
21,018.00
16,874.00
80.28
12 Sep 2025
67,861.00
44,737.00
65.92
11 Sep 2025
26,602.00
16,778.00
63.07
10 Sep 2025
15,397.00
12,846.00
83.43
09 Sep 2025
13,815.00
9,797.00
70.92
08 Sep 2025
7,201.00
3,468.00
48.16
05 Sep 2025
8,915.00
5,284.00
59.27
04 Sep 2025
7,844.00
4,077.00
51.98
03 Sep 2025
6,347.00
4,215.00
66.41
02 Sep 2025
9,207.00
4,884.00
53.05
01 Sep 2025
19,119.00
10,705.00
55.99
Please wait ...